{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:19:04Z","timestamp":1794943144793,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41401-021-00754-w","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T07:03:29Z","timestamp":1630393409000},"page":"1808-1820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation"],"prefix":"10.1038","volume":"42","author":[{"given":"Zhen-ning","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-xiao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-xu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-yang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"754_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209\u201318.","journal-title":"J Clin Invest"},{"key":"754_CR2","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830\u201341.","journal-title":"Gut"},{"key":"754_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00042737-200402000-00001","volume":"16","author":"FW Shek","year":"2004","unstructured":"Shek FW, Benyon RC. How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur J Gastroenterol Hepatol. 2004;16:123\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"754_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","volume":"63","author":"I Mannaerts","year":"2015","unstructured":"Mannaerts I, Leite SB, Verhulst S, Claerhout S, Eysackers N, Thoen LF, et al. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J Hepatol. 2015;63:679\u201388.","journal-title":"J Hepatol"},{"key":"754_CR5","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","volume":"157","author":"D Yimlamai","year":"2014","unstructured":"Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, et al. Hippo pathway activity influences liver cell fate. Cell. 2014;157:1324\u201338.","journal-title":"Cell"},{"key":"754_CR6","doi-asserted-by":"publisher","first-page":"ra77","DOI":"10.1126\/scisignal.2004060","volume":"6","author":"C Yi","year":"2013","unstructured":"Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC, et al. The p130 isoform of angiomotin is required for YAP-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal. 2013;6:ra77.","journal-title":"Sci Signal"},{"key":"754_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0168-8278(00)80244-5","volume":"32","author":"EJ Williams","year":"2000","unstructured":"Williams EJ, Gaca MD, Brigstock DR, Arthur MJ, Benyon RC. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol. 2000;32:754\u201361.","journal-title":"J Hepatol"},{"key":"754_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00383-004-1254-z","volume":"21","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Hayashi N, Hayashi K, Yamataka A, Lane GJ, Miyano T. Connective tissue growth factor and progressive fibrosis in biliary atresia. Pediatr Surg Int. 2005;21:12\u20136.","journal-title":"Pediatr Surg Int"},{"key":"754_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2010.11.025","volume":"55","author":"L Chen","year":"2011","unstructured":"Chen L, Charrier AL, Leask A, French SW, Brigstock DR. Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor. J Hepatol. 2011;55:399\u2013406.","journal-title":"J Hepatol"},{"key":"754_CR10","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1074\/jbc.M113.529115","volume":"289","author":"SE Hiemer","year":"2014","unstructured":"Hiemer SE, Szymaniak AD, Varelas X. The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells. J Biol Chem. 2014;289:13461\u201374.","journal-title":"J Biol Chem"},{"key":"754_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jhep.2015.05.031","volume":"63","author":"MV Machado","year":"2015","unstructured":"Machado MV, Michelotti GA, Pereira TA, Xie G, Premont R, Cortez-Pinto H, et al. Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. J Hepatol. 2015;63:962\u201370.","journal-title":"J Hepatol"},{"key":"754_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.intimp.2013.07.021","volume":"17","author":"S Huang","year":"2013","unstructured":"Huang S, Chen M, Ding X, Zhang X, Zou X. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway. Int Immunopharmacol. 2013;17:585\u201392.","journal-title":"Int Immunopharmacol"},{"key":"754_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1158\/1940-6207.CAPR-10-0033","volume":"3","author":"YJ Kim","year":"2010","unstructured":"Kim YJ, Lee JS, Hong KS, Chung JW, Kim JH, Hahm KB. Novel application of proton pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression. Cancer Prev Res (Phila). 2010;3:963\u201374.","journal-title":"Cancer Prev Res (Phila)"},{"key":"754_CR14","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-06-4095","volume":"67","author":"A De Milito","year":"2007","unstructured":"De Milito A, Iessi E, Logozzi M, Lozupone F, Spada M, Marino ML, et al. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res. 2007;67:5408\u201317.","journal-title":"Cancer Res"},{"key":"754_CR15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1128\/AAC.02043-15","volume":"60","author":"NN Liu","year":"2015","unstructured":"Liu NN, K\u00f6hler JR. Antagonism of fluconazole and a proton pump inhibitor against Candida albicans. Antimicrob Agents Chemother. 2015;60:1145\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"754_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57174-4","volume":"10","author":"M Lu","year":"2020","unstructured":"Lu M, Yan H, Yu C, Yuan L, Sun S. Proton pump inhibitors act synergistically with fluconazole against resistant Candida albicans. Sci Rep. 2020;10:498.","journal-title":"Sci Rep"},{"key":"754_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/039463200401700313","volume":"17","author":"L Scaringi","year":"2004","unstructured":"Scaringi L, Cornacchione P, Ayroldi E, Corazzi L, Capodicasa E, Rossi R, et al. Omeprazole induces apoptosis in Jurkat cells. Int J Immunopathol Pharmacol. 2004;17:331\u201342.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"754_CR18","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.1158\/1078-0432.CCR-04-1065","volume":"10","author":"M Yeo","year":"2004","unstructured":"Yeo M, Kim DK, Kim YB, Oh TY, Lee JE, Cho SW, et al. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res. 2004;10:8687\u201396.","journal-title":"Clin Cancer Res"},{"key":"754_CR19","doi-asserted-by":"publisher","first-page":"e20143","DOI":"10.1371\/journal.pone.0020143","volume":"6","author":"A Udelnow","year":"2011","unstructured":"Udelnow A, Kreyes A, Ellinger S, Landfester K, Walther P, Klapperstueck T, et al. Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. PLoS ONE. 2011;6:e20143.","journal-title":"PLoS ONE"},{"key":"754_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.67","volume":"1","author":"ML Marino","year":"2010","unstructured":"Marino ML, Fais S, Djavaheri-Mergny M, Villa A, Meschini S, Lozupone F, et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis. 2010;1:e87.","journal-title":"Cell Death Dis"},{"key":"754_CR21","doi-asserted-by":"publisher","first-page":"109478","DOI":"10.1016\/j.biopha.2019.109478","volume":"120","author":"ZN Lu","year":"2019","unstructured":"Lu ZN, Shi ZY, Dang YF, Cheng YN, Guan YH, Hao ZJ, et al. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo. Biomed Pharmacother. 2019;120:109478.","journal-title":"Biomed Pharmacother"},{"key":"754_CR22","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.biopha.2017.11.028","volume":"97","author":"HM Eltahir","year":"2018","unstructured":"Eltahir HM, Nazmy MH. Esomeprazole ameliorates CCl4 induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic, and apoptotic markers. Biomed Pharmacother. 2018;97:1356\u201365.","journal-title":"Biomed Pharmacother"},{"key":"754_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jphp.12870","volume":"70","author":"T Nishi","year":"2018","unstructured":"Nishi T, Yamamoto Y, Yamagishi N, Iguchi M, Tamai H, Ito T, et al. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats. J Pharm Pharmacol. 2018;70:383\u201392.","journal-title":"J Pharm Pharmacol"},{"key":"754_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke I, Dapito DH, Aff\u00f2 S, Uchinami H, Schwabe RF. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat Protoc. 2015;10:305\u201315.","journal-title":"Nat Protoc"},{"key":"754_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","volume":"68-69","author":"E Roeb","year":"2018","unstructured":"Roeb E. Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol. 2018;68-69:463\u201373.","journal-title":"Matrix Biol"},{"key":"754_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm0897-917","volume":"3","author":"G Ambrosini","year":"1997","unstructured":"Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917\u201321.","journal-title":"Nat Med"},{"key":"754_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ceb.2006.08.015","volume":"18","author":"DC Altieri","year":"2006","unstructured":"Altieri DC. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol. 2006;18:609\u201315.","journal-title":"Curr Opin Cell Biol"},{"key":"754_CR28","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/hep.21135","volume":"43","author":"E Wiercinska","year":"2006","unstructured":"Wiercinska E, Wickert L, Denecke B, Said HM, Hamzavi J, Gressner AM, et al. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology 2006;43:1032\u201341.","journal-title":"Hepatology"},{"key":"754_CR29","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1021\/pr3000927","volume":"11","author":"ST Rashid","year":"2012","unstructured":"Rashid ST, Humphries JD, Byron A, Dhar A, Askari JA, Selley JN, et al. Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver. J Proteome Res. 2012;11:4052\u201364.","journal-title":"J Proteome Res"},{"key":"754_CR30","doi-asserted-by":"publisher","first-page":"G720","DOI":"10.1152\/ajpgi.00310.2020","volume":"320","author":"J Yan","year":"2021","unstructured":"Yan J, Hu B, Shi W, Wang X, Shen J, Chen Y, et al. Gli2-regulated activation of hepatic stellate cells and liver fibrosis by TGF-\u03b2 signaling. Am J Physiol Gastrointest Liver Physiol. 2021;320:G720\u201328.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"754_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2018.10.030","volume":"73","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Du J, Wang S, Shao L, Jin K, Li F, et al. OTUB2 promotes cancer metastasis via hippo-independent activation of YAP and TAZ. Mol Cell. 2019;73:7\u201321.e7.","journal-title":"Mol Cell"},{"key":"754_CR32","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","volume":"90","author":"SC Yanguas","year":"2016","unstructured":"Yanguas SC, Cogliati B, Willebrords J, Maes M, Colle I, van den Bossche B, et al. Experimental models of liver fibrosis. Arch Toxicol. 2016;90:1025\u201348.","journal-title":"Arch Toxicol"},{"key":"754_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","volume":"254","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic fibrosis\u2014overview. Toxicology. 2008;254:120\u20139.","journal-title":"Toxicology"},{"key":"754_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/liv.12048","volume":"33","author":"CC Duwaerts","year":"2013","unstructured":"Duwaerts CC, Gehring S, Cheng CW, van Rooijen N, Gregory SH. Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury. Liver Int. 2013;33:255\u201365.","journal-title":"Liver Int"},{"key":"754_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.abb.2014.02.015","volume":"548","author":"E Novo","year":"2014","unstructured":"Novo E, Cannito S, Paternostro C, Bocca C, Miglietta A, Parola M. Cellular and molecular mechanisms in liver fibrogenesis. Arch Biochem Biophys. 2014;548:20\u201337.","journal-title":"Arch Biochem Biophys"},{"key":"754_CR36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","volume":"21","author":"XH Feng","year":"2005","unstructured":"Feng XH, Derynck R. Specificity and versatility in TGF-beta signaling through Smads. Annu Rev Cell Dev Biol. 2005;21:659\u201393.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"754_CR37","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 2007;17:2054\u201360.","journal-title":"Curr Biol"},{"key":"754_CR38","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130:1120\u201333.","journal-title":"Cell"},{"key":"754_CR39","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/hep.25769","volume":"56","author":"H Bai","year":"2012","unstructured":"Bai H, Zhang N, Xu Y, Chen Q, Khan M, Potter JJ, et al. Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology. 2012;56:1097\u2013107.","journal-title":"Hepatology"},{"key":"754_CR40","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/bph.13766","volume":"174","author":"M Ge","year":"2017","unstructured":"Ge M, Liu H, Zhang Y, Li N, Zhao S, Zhao W, et al. The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the Yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy. Br J Pharmacol. 2017;174:1147\u201360.","journal-title":"Br J Pharmacol"},{"key":"754_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425\u201379.","journal-title":"Annu Rev Biochem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00754-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00754-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00754-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T02:05:28Z","timestamp":1675649128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00754-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1038\/s41401-021-00754-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"assertion":[{"value":"11 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}